Trials and Fibrillations with Dr John Mandrola

View all posts »

The changing role of rhythm-control medicines for AF

Aug 4, 2012 18:24 EDT


I get a lot of questions about heart-rhythm drugs. You probably do, too. They have been around for so long, it's easy to forget just how complicated they are. These are potent chemicals that manipulate complex cardiac channels. That makes me nervous. It's one thing to prescribe flecainide; it's yet another to swallow the hard white pill yourself.

To be specific, I am talking about the sodium-channel blockers propafenone (Rhythmol, GlaxoSmithKline) and flecainide, the potassium channel blockers sotalol and dofetilide, and the multichannel blockers dronedarone and amiodarone.

As an exercise, put yourself in the shoes of a patient-safety advocate assigned to study the use of rhythm-control meds for atrial fibrillation. The first thing an outside observer would notice is how poorly these drugs work—in less than half the cases. Then they'd cringe when reading about proarrhythmia. A partially effective drug that slows the heart rate so much that a permanent in-dwelling vascular device must be implanted; this is acceptable? Or worse: AF drugs can perpetuate truly dangerous tachycardia like 1:1 atrial flutter or torsades de pointes. And if inefficacy and dangerous proarrhythmia were not enough, there's also the side effects: metallic taste, fatigue, dyspnea, blurred vision, balance problems, and stomach upset, among so many others. Ouch. How did these drugs get approved? What will we think 20 years from now?

But yet, those of us who treat AF recommend these medicines every day. Not all AF patients are best treated with catheter ablation or a rate-control approach.

Given the "new" landscape of AF therapy, perhaps it might be reasonable to reflect on how these medicines fit into the current-day treatment of AF. So much has changed: on the one hand, mere mortals can safely ablate AF in two hours. On the other hand, we are gradually learning that more treatment might not always be the best strategy. Less-is-more thinking now enjoys a strong tailwind.

Five ideas about rhythm control medicines come to mind:

Consider individuals vs populations: Even though rhythm meds work for AF less than half the time, if they work for you, it counts as a 100% success rate. This happens. We all have these patients.

To foster AF remission: I often tell AF patients "what was isn't always what is or what will be." Things can change. We know that AF begets AF and that regular rhythm probably begets regular rhythm. I often use rhythm meds as an initial tempering measure. Let's get things settled down and then talk about weaning off the medicine in the future. Sometimes AF passes as mysteriously as it comes.

To promote atrial remodeling before ablation: As an AF ablationist, I'm often using rhythm meds to prepare patients for ablation. For years, it has been clear to me that converting persistent AF to intermittent AF before ablation made sense. It's exciting to read that this strategy reduced the intensity of ablation needed to achieve success .

To buy time: We see a great deal of lifestyle-associated AF in Kentucky. I often use rhythm drugs to give symptomatic AF patients a window of time to right their ship. You know the cycle: AF makes it tough to exercise; lack of exercise causes weight gain, which then worsens blood pressure and sleep, which then sustains AF, and sustained AF leads to atrial structural disease. If you can get a patient in sinus rhythm, you can give them an opportunity to help themselves. They can run (or walk or cycle) with the vigor that sinus rhythm brings.

This would be a good place to mention the incredibly novel drug dofetilide (Tikosyn, Pfizer). Although it's tricky to use, I often find it surprising helpful in seemingly hopeless cases of persistent AF. The word miraculous comes to mind. I've seen dofetilide superresponders—sometimes with both dilated bellies and dilated atria—convert with one oral dose and then remain in regular rhythm for years. When this happens I turn up the volume on lifestyle: "Wow . . . Congratulations. . . . Now that you are in sinus rhythm, you need to get moving. You can help yourself." Seriously, this is a beautiful event—even though Pfizer did it, not me.

One more thing on buying time: AF ablation has come a long way over the past 10 years. It's now a "normal" procedure. But still, from a patient's perspective, it's far from easy or small. Redo procedures are common, and life-changing complications can happen. Surely AF ablation will get better in the future. So here's another area for using rhythm-control medicines. Let's say a medicine is nicely controlling AF. Why not wait to ablate? AF ablation will not be any different in the next month, but it will surely be better in two years.

Pill in the pocket: The pill-in-the-pocket technique appeals to me. It's not just that the strategy graced the pages of the New England Journal of Medicine, it also jives with my minimalist bent. What's better: taking two pills a year for two AF episodes or 760 pills for suppressing the two episodes?

Even though most of the pill-in-the-pocket studies evaluated rhythm-control drugs, I've had modest success, especially in cases of early or adrenaline-sensitive AF, with simple beta blockers taken as needed for episodes. (Think safety. Think empowering the patient. Think staying out of the ER.) For patients who are well-educated on their disease, have infrequent episodes of AF, and been evaluated by an expert who has assessed the appropriateness of the drug, this minimalist technique can work well. I've even used it on myself.

Surely there are many other good reasons to use rhythm drugs for treating AF.

It would be cool to hear your ideas.

JMM








Your comments
The changing role of rhythm-control medicines for AF
# 1 of 18
August 4, 2012 08:23 (EDT)
Ken Grauer, MD

GREAT post! The only 2 points I'd add would be: i) to reemphasize what you've said in previous columns - namely that one very valid approach for certain patients (esp. older ones with longterm AFib) is rate control with aticoagulation and not even thinking about rhythm control; and ii) that a 6th reason to consider antiarrhythmic drugs is because the patient asks for this (perhaps because they are not yet ready to have an ablation procedure). In a sense - that's another way to "buy time".

 Again - GREAT post - and  I think you covered the key points extremely well (and in proper perspective). 

# 2 of 18
August 5, 2012 10:47 (EDT)
Alexandra

First, thanks very much indeed for your articles and blog.  As a 70-yar old lone AF patient in the UK I find them helpful, clear and entertaining.  I realise that you can't comment on my personal case.  I am seeking your general opinion on the effect of AF medications on the patient's capacity to exercise.

At 5'9" and 116lbs I run, walk and train with weights, don't drink or smoke and eat an obsessively healthy diet.  My problem is that I am currently taking a 5mg beta blocker as a pill in the pocket.  I am not sure if that helps curtail my AF episodes, but I AM sure that the beta blockers hold down my HR so that it is hard for me to do aerobic exercise for the two days following an attack.  Thus each AF episode costs me 3 days of exercise.  If I DON'T take the beta blockers the attack may or may not last longer (they are so variable it is impossible to judge) but I only lose 2 days - one for the attack, one to recover and the 3rd I'm OK.  

As you are an advocate for exercise, please could you tell me whether a different pill in the pocket (eg Flecainide) might have a less negative effect on my sporting life than beta blockers?  It has been suggested that I take Dronedarone regularly, as my AF is linked to my digestive problems. Is this known to affect exercise capacity?  I am sure you will appreciate how important these questions are for me. Thank you.

# 3 of 18
August 5, 2012 01:08 (EDT)
Cliff

One aspect I have seen unfortunately too little recognition of, even today, is that when it comes to AF drugs, one class - Beta blockers - is not always very good for one class of AF sufferers - vagal - especially symptomatic ones.  I was "fortunate enough" to suffer from asthma and for that reason have never been prescribed Beta blockers, but my AF was/is clearly strongly vagally mediated, as is the case for many fit, active people including sportspersons.  Other AF drugs I have had also slow the heart and made my AF worse, though flecainide seems to be OK for me. 

But my heart sinks every time I see someone saying "I can't run/walk/hike/bike any more since I was prescribed beta blockers". Especially as it is often followed up by "and they don't convert me back to sinus, either". Nope, they're probably taking you further away from sinus.

Now, I know there are other reasons why Beta Blockers are considered, but each time they are considered, make sure the sufferer is not vagal, and even if the vagal/adrenergic balance is not clear (as it often isn't), if they're a sportsperson then give htem the benefit of the doubt and find somethign that doesn't slow their rate.

# 4 of 18
August 5, 2012 03:15 (EDT)
taoshum

Thanks, once again, for sharing your knowledge and insight.

From one with parox Afib... on regular flecainide and toprol, who still has episodes every now and then... no discernible patterns of course... When there is an episode, it feels like a near death situation, especially with low BP from extra toprol, flecainide and aspirin.  In the midst of those situations, ablation would be a welcomed option.  Once it reverts, after minutes or hours or days... life is fine again... why mess with ablation.  So the big dilemma is "what to do next?"  Try to live under the black cloud of parox Afib or go have an ablation and "hope" that it eliminates the problem(s) and doesn't introduce any new ones.  Flip a coin?  OK, it's heads... so it's time to go have an ablation.  I'll let you know if it was the right decision for me.  There's only a 3-4 week delay between decision and the actual procedure.  How many people back away at the last minute?  Will I?

# 5 of 18
August 5, 2012 04:57 (EDT)
Mike Early

Excellent piece and timely for me.  I was relatively AF free on a set of medications for 3.5 years.  Late June went to AF and would not convert with medication.  Had a cardioversion and remained on same medication for 32 days and went to artial flutter.  Additional doses of same medication unsuccessful and required cardioversion on 1 August. My cardiologist referred me to the EP to discuss options.  The EP increased the doses of Rythmol from 325 to 425 mg twice daily. He discussed dofetilide, flutter ablation and AF ablation as a path to pursue. 

I have a "tough" time grasping the impact of AF.  First medical issue that hasn't been able to be fixed with medicine, stitches or replacement.  The uncertainty of the next episode is difficult to deal with and determine how much I want to stretch the limits of exercise.  

I sincerelt appreciate your articles and blog.

 

# 6 of 18
August 6, 2012 12:01 (EDT)
Rudy

Excellent article. I am fairly new to Afib. Had Afib, had a cardioversion and then went into V-Tach. I am 69 years old and was very active walking, exercising and on the treadmill.   I am Afib free for 2 months but have a fear of being active again. Took Amioderone 600mg. for a month and now take 200 mg. My cardiologist tells me to stop the Amioderone but I still have the fear of going out of rythem if I do. After i had V-Tach I had an ICD put in but I am also looking into having ablation . 

 I appreciate any thoughts or sugestions.

 

# 7 of 18
August 8, 2012 08:56 (EDT)
Brenda

As a patient of occasional a-fib, and a person very sensitive to medications, I prefer this 'wait and see' approach, or as I like to call it, 'wait and investigate'. For others in a similar situation, I believe doctors could encourage patients to explore the root cause or what may trigger these episodes, rather than offer only meds with potentially serious side effects and/or ablation, which is not without it's own dangers. 

I suspect it may have been blood pressure meds that triggered my a-fib in the first place.  Through a plant-based low sodium diet, I was able to completely stop the bp meds. I've further learned that my a-fib is induced by sulfates and food additives, particularly flavor enhancers (MSG, etc).  There is research pointing to the correlation between heart arrythmias and the mountain of preservatives and chemicals in the American diet: Why not explore these possibilities as well? Astonishingly, I have yet to find a cardiologist to suggest this. I've been frustrated and confused by pressure to immediately begin anti-arrhythmic drugs and/or schedule an ablation.

I appreciate the honesty of this informative article.

# 8 of 18
August 9, 2012 01:32 (EDT)
john

It should be recommended that patients with poor diets or who are on acid blocking therapy be sure they are not magnesium depleted as determined by serum or RBC magnesium studies.  Oral magnesium is cheap, almost impossible to overdose if taken orally (providing normal kidney function) and wonderful for A Fib.  Acid blockers such as Proton Pump Inhibitors and H2 receptor blockers all decrease magnesium absorption.

Taurine 1-2 grams three times daily can also be used for adrenaline sensitive patients and has been shown to decrease PACs and PVCs. 

 

# 9 of 18
August 17, 2012 09:29 (EDT)
Richard
What about Vernakalant? It isn't approved in the US yet though.
# 10 of 18
August 17, 2012 10:56 (EDT)
Paula
I read this article and feel a little nervous for myself in regards to my medication. I am 55 years old, female, a school teacher and in otherwise good health. I believe I started to have AFib/Flutter in my early 30's but was always told I had anxiety and was treated with xanax. I became increasingly frustrated with my Dr's diagnosis so finally sought out a cardiologist who monitored me several times to finally get what was happening. I underwent an  Afib/Flutter ablation in February of 2010. I continue to take Flecainide 100 two times a day and a 10 mg Zebeta. I tried to go off of the meds a few months after the ablation but found that I felt more comfortable staying on them. I have had only a couple of AFib episodes since the ablation but am scared to death of them when they happen. My life is 95% better since the ablation but the procedure not a walk in the park so I really am not excited to have a "touch up." I think this article is very informative but it has left me questioning the continuation of my meds the way they are. They do provide peace of mind for me.
# 11 of 18
August 17, 2012 06:47 (EDT)
Anodyne

I liked your article very much as it gave he options and your thinking behind those options.

I am slightly concerned about all the comments of those people who say they are vagal.  Do you believe in the vagal mediated afib?

When I first got mine, I always went into afib at night or possibly late afternoon.  Vagal, right?  Unfortunately I was the wrong age, sex, and weight for it.  They checked out apnea, treatment of which did in fact cause the afib to occur more during the afternoon.

Almost all afib meds drove my blood pressure low, enough so they would discontinue use and it was always a worry, but I also found that when they drove the heart rate too low when I was not in afib; I actually could tell when I was going to go into afib soon.   My body would feel peculiar and I would welcome the afib to get me over it.

I would be interested in your opinions about vagal afib, etc.

 

 

 

# 12 of 18
August 17, 2012 08:06 (EDT)
eva

Thanks for a very interesting article, with which I agree as best as I can with my own experience knowledge.

I have just had my 4th electrocardioversion in 7 and a half years! I am a paroxysmal AF68 year old woman, with no other health problems.

I have been using a regime of Sotalol 2x40 mg-day during this time.  From my understanding and reading of your article, I can assume that the sotalol is nearly as a prophylaxis as when I do have an AF episode, additional such medication does not revert the condition.  Nor, have I ever self converted back into sinus rhythm.

I believe I am fortunate to have a plan which works, ie. ambulance, hospital and cardioversion asap.

Would the readers here think that I should just continue as is, or venture into another medication etcetc?

I have never suffered with hypertension.  I am overweight, but relatively fit. The sotalol keeps my heart rate on the low side, but it makes me tired sooner from every day activities etc.

It would be nice to hear other view points. thanks for this opportunity.

# 13 of 18
August 18, 2012 01:20 (EDT)
JJ

After 8 years of paroxysmal AF and 6 drugs, including ones mentioned favorably above, my very symptomatic episodes were becoming more frequent and lasting longer, up to a week with shorter respites. Three ablations in 2011 (male, 69 yrs old, strong heart) accompanied by 4 cardioverts + a pacemaker did the job. (Ablations pain free...worst part anesthesia hangover for few days.)  After a couple months of healing in the heart, of which I had no sensation, the AF did not recur. It's been 6 months now and I exercise regularly and enjoy 2 glasses of wine daily.

Fleckanide 100 2x daily + metoprol 100mg (also for BP ) but will reconsider with MD after this excellent blog post. At least will supplement magnesium. Pacemaker keeps HR ar 72 vs historic norm of 50ish (good genes + years running)  

Quality of life dramatically improved!  Would do it again if necessary but realize damage potential to heart fron multi- ablations. I think "fried" is the word I've heard. Life is good!

# 14 of 18
August 18, 2012 11:16 (EDT)
Wendell

Dear Dr.

I was shocked to learn about dofetillide.  Never heard of it??

If it is such a wonderful drug, how come it is not more commonly used???

I am 73 with persistent A-fib.

Thanks,

Wendell williams

# 15 of 18
August 18, 2012 11:35 (EDT)
John Mandrola

WW,

The reason why dofetilide isn't that well known or commonly used is because it is a complex medicine that has to be used carefully and only by experts. The medicine must be initiated in the hospital over 3 days. The prescribing doctor has to have completed a special course on the drug. It is cleared by the kidneys and has numerous drug-drug interactions. Finally, it is a potent QT-prolonger. 

But yet, AF doctors, especially AF ablationists, use a lot of tikosyn. As I wrote, the drug sometimes works like magic.

I would not and should not give medical advice over the internet. When AF patients write to me with their AF story, I answer with the same response: You should discuss your case with your doctor--and it's okay to seek out numrous opinions. Two things are true about AF therapy: In many cases, there is often a couple different ways to treat the disease, and two, knowledge and expertise about AF treatment varies considerably in the cardiology community.

JMM 

# 16 of 18
August 19, 2012 12:31 (EDT)
wendell

Dear Dr.,

I have been very impressed reading your blog ;and your answering me on a Saturday nite put the icing on the cake.

I wish you lived in the S.F. Bay area (I live in Sonoma). If and when I get ready for ablation you can be sure I will chose you.

Sincerely,

Wendell H. Williams

Former Democratic Nominee

U.S. Congress (Calif)

# 17 of 18
August 21, 2012 07:39 (EDT)
Abdulsater Rifai
  

Thank you Dr. John Mandrola for interesting article. As a 59 years old cardiologist with paroxysmal AF, I would like to share some ideas with you and your readers, and I hope to read your comments on them:  

1.       Most, if not all, my paroxysms started in the night and awaked me because of severe palpitation, chest discomfort and sweating. I discovered that lying in the left side was the trigger of AF episode, and after avoiding that position I became free of any episodes during the last two years. I searched the literature for positional AF, but I didn’t find enough information!

2.       During AF paroxysm, I took 40 mg and sometimes 80 mg of propranolol to relieve the symptoms, and it partially works. The rhythm – thank God- converted spontaneously to sinus in no more than five hours. So, prescribing beta blockers during the attack which converted spontaneously seems advisable.

3.       I tried beta blockers as a prophylaxis – before I discovered my positional trigger for AF- but it doesn’t work, nor was ACE inhibitor or statin.

4.       When the paper of pill-in-the pocket approach was published, I prescribed them to some of my patients; but as I have risk factors for coronary artery disease (rich family history, hypercholesterolemia, age, sex) I felt it could be dangerous to try taking class Ic antiarrhythmic medication!

5.       One of my colleagues told me that his paroxysmal AF was disappeared after using proton pump inhibitor for potential gastro-esophageal reflux.

6.       The last, but not the least, point I like to mention is that keeping patients of AF in sinus rhythm should be our goal, and we should try all the tricks we learned to do that. Although the studies say that controlling ventricular response of AF or converting AF to sinus rhythm will have the same mortality percentage, quality of life is very important. And if you experienced an episode of AF you can tell the difference between normal sinus rhythm and abnormal AF rhythm!   

# 18 of 18
August 24, 2012 02:28 (EDT)
Al

The pill in the pocket approach is useful, however can you clarify a couple things:  When this was reported in NEJM, there is clearly a description in Methods that these patients were all treated in a monitored setting, prior to being given a Rx for outpatient use.  I think that is often ignored.  Do you use this only on those whose first use of propafenone or flecainide is in the hospital or ER? 

Detection and treatment of sleep apnea is underappreciated as an adjunct to prevent recurrences of afib.  How much do you push to add ACE inhibitors and statins, both of which have been shown to decrease the likelihood of recurrence of afib?


You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

About the author

Dr John Mandrola practices cardiac electrophysiology in Louisville, KY. He finished training at Indiana University in 1996. His practice encompasses catheter ablation, including an eight-year experience with AF ablation, device implantation, and consultative EP. Outside of the EP lab, Dr Mandrola's two hobbies include competitive cycling and writing. He has maintained a medical, fitness, and cycling blog, Dr John M, for the past two years.